CLINICAL TRIALS PROFILE FOR LITHOSTAT
✉ Email this page to a colleague
All Clinical Trials for LITHOSTAT
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Children's Hospital of Philadelphia | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Data Management and Coordinating Center (DMCC) | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| NCT02670889 ↗ | Manipulating the Gut Microbiome Study | Terminated | Nicholas Ah Mew | Phase 1/Phase 2 | 2017-03-24 | The objective is to determine if acetohydroxamic acid (AHA) can prevent hydrolysis of urea by inhibiting the bacterial urease of gut flora of both healthy control adults as well as adults with urea cycle disorders |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LITHOSTAT
Condition Name
| Condition Name for LITHOSTAT | |
| Intervention | Trials |
| Urea Cycle Disorder | 2 |
| Argininosuccinate Synthetase Deficiency (Citrullinemia) | 1 |
| Argininosuccinic Acid Lyase Deficiency (Argininosuccinic Aciduria) | 1 |
| [disabled in preview] | 0 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
Clinical Trial Locations for LITHOSTAT
Trials by Country
Clinical Trial Progress for LITHOSTAT
Clinical Trial Phase
Clinical Trial Sponsors for LITHOSTAT
Sponsor Name
